Cyclophosphamide
UCDCC#303
Phase 2 small_molecule active
Quick answer
Cyclophosphamide for Double-Expressor Lymphoma is a Phase 2 program (small_molecule) at ADC Therapeutics SA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ADC Therapeutics SA
- Indication
- Double-Expressor Lymphoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active